Nanocarriers for Nanomedicine
Abstract
The development of nano-carriers as therapeutic and diagnostic tools represents one of the most dynamic technological frontiers in the treatment of different pathological conditions such as cancer or neurological diseases. Nanomedicine could therefore represent the future of nanotechnology in fighting unexpected diseases or to overcome pandemic outbreaks. In this seminar I will make an overview of our recent progress in nano-carriers design as nano-delivery tools to target neuronal and neoplastic cells.Possible uses and future perspectives of such nano-vehicles in current medical praxis will be envisaged.
References:
[1] N. A.N. Hanafy, M. Elkemary and S. Leporatti "Micelles Structure Development as a Strategy to Improve Smart Cancer Therapy" Cancers 2018, 10, 238; doi:10.3390/cancers10070238. A-M. Safer, S. Leporatti, J. Jose, M. S. Soliman "Conjugation of EGCG and Chitosan NPs as a novel Nano-Drug Delivery System" International Journal of Nanomedicine 2019:14 8033–8046.
[2] Francesca Persano and Stefano Leporatti "Current Overview of inorganic nanoparticles for the treatment of central nervous system (CNS) diseases" Current Nanomaterials 2020, 5(2): 92 - 110, DOI:10.2174/2468187310999200430093239.
[3] S Leporatti, M. Cascione, V. De Matteis, R. Rinaldi “Design of Nano-Clays for Drug Delivery and Bio-Imaging: Can Toxicity be an Issue?” Nanomedicine-Future Medicine 15, 25, 2020 (Published Online: 3 Sep 2020). https://doi.org/10.2217/nnm-2020-0283.
[4] F Persano, S Batasheva, GI Fakhrullina, G Gigli, S Leporatti, RF Fakhrullin "Recent Advances in the Design of Inorganic and Nano-Clays Particles for the Treatment of Brain Disorders "Journal of Materials Chemistry B (2021) , 9(12) 2726. https://doi.org/10.1039/D0TB02957B.